nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—Pimecrolimus—atopic dermatitis	0.0869	0.122	CbGbCtD
Tolvaptan—ABCB1—Tacrolimus—atopic dermatitis	0.0862	0.121	CbGbCtD
Tolvaptan—ABCB1—Loratadine—atopic dermatitis	0.0631	0.0888	CbGbCtD
Tolvaptan—ABCB1—Methylprednisolone—atopic dermatitis	0.0577	0.0813	CbGbCtD
Tolvaptan—CYP3A4—Tacrolimus—atopic dermatitis	0.0517	0.0727	CbGbCtD
Tolvaptan—CYP3A4—Loratadine—atopic dermatitis	0.0378	0.0532	CbGbCtD
Tolvaptan—ABCB1—Betamethasone—atopic dermatitis	0.0375	0.0528	CbGbCtD
Tolvaptan—ABCB1—Prednisolone—atopic dermatitis	0.037	0.0521	CbGbCtD
Tolvaptan—ABCB1—Hydrocortisone—atopic dermatitis	0.0351	0.0494	CbGbCtD
Tolvaptan—ABCB1—Prednisone—atopic dermatitis	0.035	0.0492	CbGbCtD
Tolvaptan—CYP3A4—Methylprednisolone—atopic dermatitis	0.0346	0.0487	CbGbCtD
Tolvaptan—CYP3A4—Triamcinolone—atopic dermatitis	0.0262	0.0369	CbGbCtD
Tolvaptan—CYP3A4—Betamethasone—atopic dermatitis	0.0225	0.0317	CbGbCtD
Tolvaptan—CYP3A4—Prednisolone—atopic dermatitis	0.0222	0.0312	CbGbCtD
Tolvaptan—ABCB1—Dexamethasone—atopic dermatitis	0.0218	0.0307	CbGbCtD
Tolvaptan—CYP3A4—Hydrocortisone—atopic dermatitis	0.021	0.0296	CbGbCtD
Tolvaptan—CYP3A4—Prednisone—atopic dermatitis	0.021	0.0295	CbGbCtD
Tolvaptan—CYP3A4—Dexamethasone—atopic dermatitis	0.0131	0.0184	CbGbCtD
Tolvaptan—AVPR1A—Peptide GPCRs—CCR3—atopic dermatitis	0.0023	0.0221	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CCR3—atopic dermatitis	0.00228	0.0219	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00206	0.0198	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00204	0.0196	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—CXCR3—atopic dermatitis	0.00201	0.0193	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CXCR3—atopic dermatitis	0.002	0.0191	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00184	0.0176	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00182	0.0175	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00165	0.0158	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00163	0.0157	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00138	0.0132	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00137	0.0132	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—NPS—atopic dermatitis	0.00135	0.0129	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00133	0.0127	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00132	0.0126	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—CCR5—atopic dermatitis	0.00126	0.0121	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00125	0.012	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CCR5—atopic dermatitis	0.00125	0.012	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00123	0.0118	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00122	0.0117	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.0011	0.0106	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.0011	0.0105	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00108	0.0104	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00107	0.0103	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL22—atopic dermatitis	0.00105	0.0101	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL22—atopic dermatitis	0.00104	0.01	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000977	0.00937	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—NPS—atopic dermatitis	0.000977	0.00937	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000964	0.00925	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000964	0.00925	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000957	0.00918	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000957	0.00918	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000946	0.00907	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000939	0.009	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL27—atopic dermatitis	0.000938	0.00899	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL27—atopic dermatitis	0.000931	0.00893	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00089	0.00854	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000884	0.00848	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000873	0.00838	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000873	0.00838	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000847	0.00812	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL17—atopic dermatitis	0.000841	0.00807	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000841	0.00806	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL17—atopic dermatitis	0.000835	0.00801	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Loratadine—atopic dermatitis	0.000787	0.00425	CcSEcCtD
Tolvaptan—Constipation—Pimecrolimus—atopic dermatitis	0.000785	0.00423	CcSEcCtD
Tolvaptan—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.000782	0.00422	CcSEcCtD
Tolvaptan—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.000782	0.00422	CcSEcCtD
Tolvaptan—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000775	0.00418	CcSEcCtD
Tolvaptan—Renal failure—Tacrolimus—atopic dermatitis	0.000769	0.00415	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000764	0.00733	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000759	0.00728	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.000757	0.00408	CcSEcCtD
Tolvaptan—Discomfort—Loratadine—atopic dermatitis	0.000753	0.00406	CcSEcCtD
Tolvaptan—Dry mouth—Loratadine—atopic dermatitis	0.000746	0.00402	CcSEcCtD
Tolvaptan—Pruritus—Fluocinonide—atopic dermatitis	0.000745	0.00402	CcSEcCtD
Tolvaptan—Ecchymosis—Triamcinolone—atopic dermatitis	0.000743	0.00401	CcSEcCtD
Tolvaptan—Ecchymosis—Methylprednisolone—atopic dermatitis	0.000741	0.004	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00074	0.0071	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000735	0.00705	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Loratadine—atopic dermatitis	0.000731	0.00394	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000726	0.00696	CbGpPWpGaD
Tolvaptan—Body temperature increased—Pimecrolimus—atopic dermatitis	0.000725	0.00391	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00072	0.00691	CbGpPWpGaD
Tolvaptan—Shock—Loratadine—atopic dermatitis	0.000719	0.00388	CcSEcCtD
Tolvaptan—Nervous system disorder—Loratadine—atopic dermatitis	0.000717	0.00387	CcSEcCtD
Tolvaptan—Skin disorder—Loratadine—atopic dermatitis	0.00071	0.00383	CcSEcCtD
Tolvaptan—Dizziness—Fluocinonide—atopic dermatitis	0.000696	0.00375	CcSEcCtD
Tolvaptan—Urinary tract disorder—Tacrolimus—atopic dermatitis	0.000694	0.00374	CcSEcCtD
Tolvaptan—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.000691	0.00372	CcSEcCtD
Tolvaptan—Urethral disorder—Tacrolimus—atopic dermatitis	0.000689	0.00372	CcSEcCtD
Tolvaptan—Asthenia—Diphenhydramine—atopic dermatitis	0.000681	0.00367	CcSEcCtD
Tolvaptan—Asthenia—Dimenhydrinate—atopic dermatitis	0.000681	0.00367	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL11—atopic dermatitis	0.000678	0.0065	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000676	0.00365	CcSEcCtD
Tolvaptan—Ecchymosis—Dexamethasone—atopic dermatitis	0.000674	0.00364	CcSEcCtD
Tolvaptan—Ecchymosis—Betamethasone—atopic dermatitis	0.000674	0.00364	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CCL11—atopic dermatitis	0.000673	0.00645	CbGpPWpGaD
Tolvaptan—Headache—Fluocinonide—atopic dermatitis	0.000659	0.00356	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000658	0.00631	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000653	0.00627	CbGpPWpGaD
Tolvaptan—Cardiac disorder—Tacrolimus—atopic dermatitis	0.000652	0.00352	CcSEcCtD
Tolvaptan—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000649	0.0035	CcSEcCtD
Tolvaptan—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000649	0.0035	CcSEcCtD
Tolvaptan—Pruritus—Pimecrolimus—atopic dermatitis	0.000649	0.0035	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000647	0.0062	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000647	0.0062	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.000644	0.00347	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000642	0.00616	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000642	0.00616	CbGpPWpGaD
Tolvaptan—Dry mouth—Mometasone—atopic dermatitis	0.00064	0.00345	CcSEcCtD
Tolvaptan—Angiopathy—Tacrolimus—atopic dermatitis	0.000638	0.00344	CcSEcCtD
Tolvaptan—Immune system disorder—Tacrolimus—atopic dermatitis	0.000635	0.00342	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000634	0.00608	CbGpPWpGaD
Tolvaptan—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.000633	0.00342	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000631	0.0034	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00063	0.00604	CbGpPWpGaD
Tolvaptan—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000628	0.00339	CcSEcCtD
Tolvaptan—Dizziness—Dimenhydrinate—atopic dermatitis	0.000628	0.00339	CcSEcCtD
Tolvaptan—Dizziness—Diphenhydramine—atopic dermatitis	0.000628	0.00339	CcSEcCtD
Tolvaptan—Anaphylactic shock—Mometasone—atopic dermatitis	0.000627	0.00338	CcSEcCtD
Tolvaptan—Constipation—Loratadine—atopic dermatitis	0.000625	0.00337	CcSEcCtD
Tolvaptan—Malnutrition—Tacrolimus—atopic dermatitis	0.000612	0.0033	CcSEcCtD
Tolvaptan—Feeling abnormal—Loratadine—atopic dermatitis	0.000602	0.00325	CcSEcCtD
Tolvaptan—Dysgeusia—Tacrolimus—atopic dermatitis	0.000599	0.00323	CcSEcCtD
Tolvaptan—Anorexia—Mometasone—atopic dermatitis	0.000598	0.00323	CcSEcCtD
Tolvaptan—Headache—Diphenhydramine—atopic dermatitis	0.000595	0.00321	CcSEcCtD
Tolvaptan—Headache—Dimenhydrinate—atopic dermatitis	0.000595	0.00321	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000593	0.00569	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000588	0.00564	CbGpPWpGaD
Tolvaptan—Ecchymosis—Prednisone—atopic dermatitis	0.000587	0.00317	CcSEcCtD
Tolvaptan—Body temperature increased—Loratadine—atopic dermatitis	0.000578	0.00312	CcSEcCtD
Tolvaptan—Headache—Pimecrolimus—atopic dermatitis	0.000575	0.0031	CcSEcCtD
Tolvaptan—Ill-defined disorder—Tacrolimus—atopic dermatitis	0.000568	0.00306	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000567	0.00306	CcSEcCtD
Tolvaptan—Nausea—Dimenhydrinate—atopic dermatitis	0.000564	0.00304	CcSEcCtD
Tolvaptan—Nausea—Diphenhydramine—atopic dermatitis	0.000564	0.00304	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.000559	0.00301	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCR3—atopic dermatitis	0.000553	0.0053	CbGpPWpGaD
Tolvaptan—Malaise—Tacrolimus—atopic dermatitis	0.000552	0.00298	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CCR3—atopic dermatitis	0.000549	0.00526	CbGpPWpGaD
Tolvaptan—Syncope—Tacrolimus—atopic dermatitis	0.000549	0.00296	CcSEcCtD
Tolvaptan—Decreased appetite—Mometasone—atopic dermatitis	0.000545	0.00294	CcSEcCtD
Tolvaptan—Nausea—Pimecrolimus—atopic dermatitis	0.000545	0.00294	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL22—atopic dermatitis	0.00054	0.00518	CbGpPWpGaD
Tolvaptan—Breast disorder—Methylprednisolone—atopic dermatitis	0.000538	0.0029	CcSEcCtD
Tolvaptan—Loss of consciousness—Tacrolimus—atopic dermatitis	0.000538	0.0029	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CCL22—atopic dermatitis	0.000536	0.00514	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL27—atopic dermatitis	0.00053	0.00508	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.000526	0.00505	CbGpPWpGaD
Tolvaptan—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.000525	0.00283	CcSEcCtD
Tolvaptan—Asthenia—Loratadine—atopic dermatitis	0.000524	0.00283	CcSEcCtD
Tolvaptan—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000519	0.0028	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000517	0.00279	CcSEcCtD
Tolvaptan—Discomfort—Tacrolimus—atopic dermatitis	0.000515	0.00278	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000513	0.00492	CbGpPWpGaD
Tolvaptan—Dry mouth—Tacrolimus—atopic dermatitis	0.000509	0.00275	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000509	0.00488	CbGpPWpGaD
Tolvaptan—Diarrhoea—Loratadine—atopic dermatitis	0.0005	0.0027	CcSEcCtD
Tolvaptan—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000499	0.00269	CcSEcCtD
Tolvaptan—Body temperature increased—Mometasone—atopic dermatitis	0.000496	0.00267	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—NPS—atopic dermatitis	0.000492	0.00472	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—TAC1—atopic dermatitis	0.000492	0.00472	CbGpPWpGaD
Tolvaptan—Shock—Tacrolimus—atopic dermatitis	0.000491	0.00265	CcSEcCtD
Tolvaptan—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00049	0.00264	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—NPS—atopic dermatitis	0.000489	0.00469	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—TAC1—atopic dermatitis	0.000489	0.00469	CbGpPWpGaD
Tolvaptan—Skin disorder—Tacrolimus—atopic dermatitis	0.000485	0.00262	CcSEcCtD
Tolvaptan—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000484	0.00261	CcSEcCtD
Tolvaptan—Dizziness—Loratadine—atopic dermatitis	0.000483	0.00261	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCR3—atopic dermatitis	0.000483	0.00463	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL27—atopic dermatitis	0.000481	0.00461	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00048	0.0046	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL27—atopic dermatitis	0.000478	0.00458	CbGpPWpGaD
Tolvaptan—Anorexia—Tacrolimus—atopic dermatitis	0.000476	0.00257	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Prednisone—atopic dermatitis	0.000471	0.00254	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000467	0.00448	CbGpPWpGaD
Tolvaptan—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000465	0.00251	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000464	0.00445	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000461	0.00442	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.00046	0.00442	CbGpPWpGaD
Tolvaptan—Headache—Loratadine—atopic dermatitis	0.000458	0.00247	CcSEcCtD
Tolvaptan—Asthenia—Mometasone—atopic dermatitis	0.00045	0.00243	CcSEcCtD
Tolvaptan—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000449	0.00242	CcSEcCtD
Tolvaptan—Pruritus—Mometasone—atopic dermatitis	0.000444	0.00239	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000441	0.00423	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000438	0.0042	CbGpPWpGaD
Tolvaptan—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000434	0.00234	CcSEcCtD
Tolvaptan—Nausea—Loratadine—atopic dermatitis	0.000434	0.00234	CcSEcCtD
Tolvaptan—Decreased appetite—Tacrolimus—atopic dermatitis	0.000434	0.00234	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL17—atopic dermatitis	0.000432	0.00414	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000431	0.00232	CcSEcCtD
Tolvaptan—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000431	0.00232	CcSEcCtD
Tolvaptan—Diarrhoea—Mometasone—atopic dermatitis	0.000429	0.00231	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CCL17—atopic dermatitis	0.000428	0.00411	CbGpPWpGaD
Tolvaptan—Constipation—Tacrolimus—atopic dermatitis	0.000427	0.0023	CcSEcCtD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000426	0.00408	CbGpPWpGaD
Tolvaptan—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000422	0.00228	CcSEcCtD
Tolvaptan—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000422	0.00228	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000416	0.00224	CcSEcCtD
Tolvaptan—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000412	0.00222	CcSEcCtD
Tolvaptan—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000411	0.00222	CcSEcCtD
Tolvaptan—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000405	0.00218	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.0004	0.00383	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000398	0.00381	CbGpPWpGaD
Tolvaptan—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000396	0.00214	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000395	0.00379	CbGpPWpGaD
Tolvaptan—Body temperature increased—Tacrolimus—atopic dermatitis	0.000395	0.00213	CcSEcCtD
Tolvaptan—Headache—Mometasone—atopic dermatitis	0.000393	0.00212	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL10—atopic dermatitis	0.00039	0.00374	CbGpPWpGaD
Tolvaptan—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00039	0.0021	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000388	0.00372	CbGpPWpGaD
Tolvaptan—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000382	0.00206	CcSEcCtD
Tolvaptan—Malnutrition—Hydrocortisone—atopic dermatitis	0.000382	0.00206	CcSEcCtD
Tolvaptan—Angiopathy—Methylprednisolone—atopic dermatitis	0.000374	0.00202	CcSEcCtD
Tolvaptan—Nausea—Mometasone—atopic dermatitis	0.000373	0.00201	CcSEcCtD
Tolvaptan—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000372	0.00201	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000371	0.002	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000368	0.00353	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000368	0.00198	CcSEcCtD
Tolvaptan—Hyperglycaemia—Prednisone—atopic dermatitis	0.000368	0.00198	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000363	0.00196	CcSEcCtD
Tolvaptan—Malnutrition—Methylprednisolone—atopic dermatitis	0.000359	0.00193	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000358	0.00344	CbGpPWpGaD
Tolvaptan—Asthenia—Tacrolimus—atopic dermatitis	0.000358	0.00193	CcSEcCtD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000356	0.00341	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000354	0.00191	CcSEcCtD
Tolvaptan—Pruritus—Tacrolimus—atopic dermatitis	0.000353	0.00191	CcSEcCtD
Tolvaptan—Malaise—Prednisolone—atopic dermatitis	0.000352	0.0019	CcSEcCtD
Tolvaptan—Dysgeusia—Triamcinolone—atopic dermatitis	0.000352	0.0019	CcSEcCtD
Tolvaptan—Syncope—Prednisolone—atopic dermatitis	0.00035	0.00189	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL11—atopic dermatitis	0.000348	0.00334	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL11—atopic dermatitis	0.000345	0.00331	CbGpPWpGaD
Tolvaptan—Malaise—Hydrocortisone—atopic dermatitis	0.000344	0.00186	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisolone—atopic dermatitis	0.000343	0.00185	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—FCER2—atopic dermatitis	0.000343	0.00329	CbGpPWpGaD
Tolvaptan—Syncope—Hydrocortisone—atopic dermatitis	0.000342	0.00185	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000342	0.00328	CbGpPWpGaD
Tolvaptan—Diarrhoea—Tacrolimus—atopic dermatitis	0.000342	0.00184	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—FCER2—atopic dermatitis	0.000341	0.00327	CbGpPWpGaD
Tolvaptan—Angiopathy—Betamethasone—atopic dermatitis	0.00034	0.00183	CcSEcCtD
Tolvaptan—Angiopathy—Dexamethasone—atopic dermatitis	0.00034	0.00183	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL5—atopic dermatitis	0.000336	0.00322	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000335	0.00181	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CCL5—atopic dermatitis	0.000334	0.0032	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000333	0.0018	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000333	0.00179	CcSEcCtD
Tolvaptan—Dizziness—Tacrolimus—atopic dermatitis	0.00033	0.00178	CcSEcCtD
Tolvaptan—Discomfort—Prednisolone—atopic dermatitis	0.000329	0.00177	CcSEcCtD
Tolvaptan—Malaise—Triamcinolone—atopic dermatitis	0.000324	0.00175	CcSEcCtD
Tolvaptan—Malaise—Methylprednisolone—atopic dermatitis	0.000323	0.00174	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000323	0.00174	CcSEcCtD
Tolvaptan—Syncope—Triamcinolone—atopic dermatitis	0.000322	0.00174	CcSEcCtD
Tolvaptan—Syncope—Methylprednisolone—atopic dermatitis	0.000321	0.00173	CcSEcCtD
Tolvaptan—Discomfort—Hydrocortisone—atopic dermatitis	0.000321	0.00173	CcSEcCtD
Tolvaptan—Connective tissue disorder—Prednisone—atopic dermatitis	0.00032	0.00173	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CCL22—atopic dermatitis	0.000319	0.00306	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000319	0.00172	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—CCL22—atopic dermatitis	0.000317	0.00304	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000316	0.0017	CcSEcCtD
Tolvaptan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000315	0.0017	CcSEcCtD
Tolvaptan—Shock—Prednisolone—atopic dermatitis	0.000314	0.00169	CcSEcCtD
Tolvaptan—Headache—Tacrolimus—atopic dermatitis	0.000313	0.00169	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR3—atopic dermatitis	0.000312	0.003	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000311	0.00168	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.00031	0.00297	CbGpPWpGaD
Tolvaptan—Shock—Hydrocortisone—atopic dermatitis	0.000306	0.00165	CcSEcCtD
Tolvaptan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000305	0.00165	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000303	0.00163	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCR5—atopic dermatitis	0.000303	0.0029	CbGpPWpGaD
Tolvaptan—Skin disorder—Hydrocortisone—atopic dermatitis	0.000302	0.00163	CcSEcCtD
Tolvaptan—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000302	0.00163	CcSEcCtD
Tolvaptan—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000302	0.00163	CcSEcCtD
Tolvaptan—Discomfort—Triamcinolone—atopic dermatitis	0.000302	0.00163	CcSEcCtD
Tolvaptan—Discomfort—Methylprednisolone—atopic dermatitis	0.000302	0.00163	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CCR5—atopic dermatitis	0.000301	0.00288	CbGpPWpGaD
Tolvaptan—Dry mouth—Triamcinolone—atopic dermatitis	0.000299	0.00161	CcSEcCtD
Tolvaptan—Anorexia—Hydrocortisone—atopic dermatitis	0.000297	0.0016	CcSEcCtD
Tolvaptan—Nausea—Tacrolimus—atopic dermatitis	0.000297	0.0016	CcSEcCtD
Tolvaptan—Angiopathy—Prednisone—atopic dermatitis	0.000296	0.0016	CcSEcCtD
Tolvaptan—Immune system disorder—Prednisone—atopic dermatitis	0.000295	0.00159	CcSEcCtD
Tolvaptan—Malaise—Dexamethasone—atopic dermatitis	0.000294	0.00159	CcSEcCtD
Tolvaptan—Malaise—Betamethasone—atopic dermatitis	0.000294	0.00159	CcSEcCtD
Tolvaptan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000293	0.00158	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000293	0.00158	CcSEcCtD
Tolvaptan—Syncope—Betamethasone—atopic dermatitis	0.000292	0.00158	CcSEcCtD
Tolvaptan—Syncope—Dexamethasone—atopic dermatitis	0.000292	0.00158	CcSEcCtD
Tolvaptan—Shock—Triamcinolone—atopic dermatitis	0.000288	0.00156	CcSEcCtD
Tolvaptan—Shock—Methylprednisolone—atopic dermatitis	0.000288	0.00155	CcSEcCtD
Tolvaptan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000287	0.00155	CcSEcCtD
Tolvaptan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000287	0.00155	CcSEcCtD
Tolvaptan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000287	0.00155	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CCL27—atopic dermatitis	0.000284	0.00273	CbGpPWpGaD
Tolvaptan—Skin disorder—Methylprednisolone—atopic dermatitis	0.000284	0.00153	CcSEcCtD
Tolvaptan—Malnutrition—Prednisone—atopic dermatitis	0.000284	0.00153	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR3—atopic dermatitis	0.000284	0.00272	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL27—atopic dermatitis	0.000282	0.00271	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000282	0.0027	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—NPS—atopic dermatitis	0.000278	0.00267	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000278	0.00267	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000276	0.00265	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000276	0.00265	CbGpPWpGaD
Tolvaptan—Discomfort—Dexamethasone—atopic dermatitis	0.000274	0.00148	CcSEcCtD
Tolvaptan—Discomfort—Betamethasone—atopic dermatitis	0.000274	0.00148	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000273	0.00262	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000271	0.0026	CbGpPWpGaD
Tolvaptan—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000271	0.00146	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000269	0.00145	CcSEcCtD
Tolvaptan—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000266	0.00144	CcSEcCtD
Tolvaptan—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000266	0.00144	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisone—atopic dermatitis	0.000263	0.00142	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisolone—atopic dermatitis	0.000263	0.00142	CcSEcCtD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000262	0.00252	CbGpPWpGaD
Tolvaptan—Shock—Betamethasone—atopic dermatitis	0.000262	0.00141	CcSEcCtD
Tolvaptan—Shock—Dexamethasone—atopic dermatitis	0.000262	0.00141	CcSEcCtD
Tolvaptan—Nervous system disorder—Betamethasone—atopic dermatitis	0.000261	0.00141	CcSEcCtD
Tolvaptan—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000261	0.00141	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL5—atopic dermatitis	0.000259	0.00248	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000257	0.00246	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000257	0.00138	CcSEcCtD
Tolvaptan—Malaise—Prednisone—atopic dermatitis	0.000256	0.00138	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CCL17—atopic dermatitis	0.000255	0.00245	CbGpPWpGaD
Tolvaptan—Syncope—Prednisone—atopic dermatitis	0.000255	0.00137	CcSEcCtD
Tolvaptan—Anorexia—Betamethasone—atopic dermatitis	0.000254	0.00137	CcSEcCtD
Tolvaptan—Anorexia—Dexamethasone—atopic dermatitis	0.000254	0.00137	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—CCL17—atopic dermatitis	0.000253	0.00243	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TAC1—atopic dermatitis	0.000253	0.00242	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NPS—atopic dermatitis	0.000253	0.00242	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000251	0.00241	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NPS—atopic dermatitis	0.000251	0.00241	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL10—atopic dermatitis	0.00025	0.0024	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Prednisone—atopic dermatitis	0.00025	0.00135	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000248	0.00238	CbGpPWpGaD
Tolvaptan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000246	0.00133	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000246	0.00236	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL4—atopic dermatitis	0.000243	0.00233	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000242	0.0013	CcSEcCtD
Tolvaptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000241	0.0013	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00024	0.00231	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.00024	0.00129	CcSEcCtD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000239	0.00229	CbGpPWpGaD
Tolvaptan—Discomfort—Prednisone—atopic dermatitis	0.000239	0.00129	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000239	0.00229	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL5—atopic dermatitis	0.000235	0.00225	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Prednisolone—atopic dermatitis	0.000235	0.00127	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—IL5—atopic dermatitis	0.000233	0.00224	CbGpPWpGaD
Tolvaptan—Body temperature increased—Triamcinolone—atopic dermatitis	0.000232	0.00125	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisone—atopic dermatitis	0.000232	0.00125	CcSEcCtD
Tolvaptan—Decreased appetite—Betamethasone—atopic dermatitis	0.000231	0.00125	CcSEcCtD
Tolvaptan—Decreased appetite—Dexamethasone—atopic dermatitis	0.000231	0.00125	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00023	0.00124	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00023	0.00124	CcSEcCtD
Tolvaptan—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000229	0.00124	CcSEcCtD
Tolvaptan—Shock—Prednisone—atopic dermatitis	0.000228	0.00123	CcSEcCtD
Tolvaptan—Nervous system disorder—Prednisone—atopic dermatitis	0.000227	0.00123	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—KIF3A—atopic dermatitis	0.000227	0.00218	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000226	0.00216	CbGpPWpGaD
Tolvaptan—Skin disorder—Prednisone—atopic dermatitis	0.000225	0.00121	CcSEcCtD
Tolvaptan—Asthenia—Hydrocortisone—atopic dermatitis	0.000223	0.00121	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000223	0.00214	CbGpPWpGaD
Tolvaptan—Anorexia—Prednisone—atopic dermatitis	0.000221	0.00119	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000221	0.00212	CbGpPWpGaD
Tolvaptan—Pruritus—Hydrocortisone—atopic dermatitis	0.00022	0.00119	CcSEcCtD
Tolvaptan—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000219	0.00118	CcSEcCtD
Tolvaptan—Feeling abnormal—Betamethasone—atopic dermatitis	0.000219	0.00118	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000219	0.0021	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000216	0.00117	CcSEcCtD
Tolvaptan—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000216	0.00116	CcSEcCtD
Tolvaptan—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000213	0.00115	CcSEcCtD
Tolvaptan—Dizziness—Prednisolone—atopic dermatitis	0.000211	0.00114	CcSEcCtD
Tolvaptan—Asthenia—Triamcinolone—atopic dermatitis	0.00021	0.00113	CcSEcCtD
Tolvaptan—Body temperature increased—Betamethasone—atopic dermatitis	0.00021	0.00113	CcSEcCtD
Tolvaptan—Body temperature increased—Dexamethasone—atopic dermatitis	0.00021	0.00113	CcSEcCtD
Tolvaptan—Asthenia—Methylprednisolone—atopic dermatitis	0.00021	0.00113	CcSEcCtD
Tolvaptan—Pruritus—Triamcinolone—atopic dermatitis	0.000207	0.00112	CcSEcCtD
Tolvaptan—Pruritus—Methylprednisolone—atopic dermatitis	0.000207	0.00112	CcSEcCtD
Tolvaptan—Dizziness—Hydrocortisone—atopic dermatitis	0.000206	0.00111	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—CMA1—atopic dermatitis	0.000205	0.00197	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL11—atopic dermatitis	0.000205	0.00197	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL11—atopic dermatitis	0.000204	0.00196	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CMA1—atopic dermatitis	0.000204	0.00196	CbGpPWpGaD
Tolvaptan—Decreased appetite—Prednisone—atopic dermatitis	0.000201	0.00109	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL10—atopic dermatitis	0.0002	0.00192	CbGpPWpGaD
Tolvaptan—Diarrhoea—Methylprednisolone—atopic dermatitis	0.0002	0.00108	CcSEcCtD
Tolvaptan—Headache—Prednisolone—atopic dermatitis	0.0002	0.00108	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000199	0.00191	CbGpPWpGaD
Tolvaptan—Constipation—Prednisone—atopic dermatitis	0.000198	0.00107	CcSEcCtD
Tolvaptan—Headache—Hydrocortisone—atopic dermatitis	0.000195	0.00105	CcSEcCtD
Tolvaptan—Dizziness—Triamcinolone—atopic dermatitis	0.000194	0.00105	CcSEcCtD
Tolvaptan—Dizziness—Methylprednisolone—atopic dermatitis	0.000193	0.00104	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—STAT6—atopic dermatitis	0.000193	0.00185	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT6—atopic dermatitis	0.000192	0.00184	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Prednisone—atopic dermatitis	0.000191	0.00103	CcSEcCtD
Tolvaptan—Asthenia—Dexamethasone—atopic dermatitis	0.000191	0.00103	CcSEcCtD
Tolvaptan—Asthenia—Betamethasone—atopic dermatitis	0.000191	0.00103	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL5—atopic dermatitis	0.00019	0.00182	CbGpPWpGaD
Tolvaptan—Nausea—Prednisolone—atopic dermatitis	0.000189	0.00102	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000189	0.00181	CbGpPWpGaD
Tolvaptan—Pruritus—Dexamethasone—atopic dermatitis	0.000188	0.00102	CcSEcCtD
Tolvaptan—Pruritus—Betamethasone—atopic dermatitis	0.000188	0.00102	CcSEcCtD
Tolvaptan—Nausea—Hydrocortisone—atopic dermatitis	0.000185	0.000998	CcSEcCtD
Tolvaptan—Headache—Triamcinolone—atopic dermatitis	0.000184	0.000991	CcSEcCtD
Tolvaptan—Headache—Methylprednisolone—atopic dermatitis	0.000183	0.000989	CcSEcCtD
Tolvaptan—Body temperature increased—Prednisone—atopic dermatitis	0.000183	0.000988	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000183	0.00176	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000182	0.00175	CbGpPWpGaD
Tolvaptan—Diarrhoea—Dexamethasone—atopic dermatitis	0.000182	0.000982	CcSEcCtD
Tolvaptan—Diarrhoea—Betamethasone—atopic dermatitis	0.000182	0.000982	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000182	0.00174	CbGpPWpGaD
Tolvaptan—Dizziness—Betamethasone—atopic dermatitis	0.000176	0.000949	CcSEcCtD
Tolvaptan—Dizziness—Dexamethasone—atopic dermatitis	0.000176	0.000949	CcSEcCtD
Tolvaptan—Nausea—Triamcinolone—atopic dermatitis	0.000174	0.00094	CcSEcCtD
Tolvaptan—Nausea—Methylprednisolone—atopic dermatitis	0.000174	0.000937	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	0.000173	0.00166	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL5—atopic dermatitis	0.000172	0.00165	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL5—atopic dermatitis	0.000171	0.00164	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000171	0.00164	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Prednisone—atopic dermatitis	0.000171	0.000921	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.00017	0.00163	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR3—atopic dermatitis	0.000168	0.00161	CbGpPWpGaD
Tolvaptan—Headache—Dexamethasone—atopic dermatitis	0.000167	0.000899	CcSEcCtD
Tolvaptan—Headache—Betamethasone—atopic dermatitis	0.000167	0.000899	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—CCR3—atopic dermatitis	0.000166	0.0016	CbGpPWpGaD
Tolvaptan—Asthenia—Prednisone—atopic dermatitis	0.000166	0.000897	CcSEcCtD
Tolvaptan—Pruritus—Prednisone—atopic dermatitis	0.000164	0.000884	CcSEcCtD
Tolvaptan—Diarrhoea—Prednisone—atopic dermatitis	0.000159	0.000855	CcSEcCtD
Tolvaptan—Nausea—Dexamethasone—atopic dermatitis	0.000158	0.000852	CcSEcCtD
Tolvaptan—Nausea—Betamethasone—atopic dermatitis	0.000158	0.000852	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR5—atopic dermatitis	0.000155	0.00149	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCR5—atopic dermatitis	0.000154	0.00148	CbGpPWpGaD
Tolvaptan—Dizziness—Prednisone—atopic dermatitis	0.000153	0.000827	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—TAC1—atopic dermatitis	0.000149	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NPS—atopic dermatitis	0.000149	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TAC1—atopic dermatitis	0.000148	0.00142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NPS—atopic dermatitis	0.000148	0.00142	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	0.000147	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCR3—atopic dermatitis	0.000146	0.0014	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCR3—atopic dermatitis	0.000145	0.00139	CbGpPWpGaD
Tolvaptan—Headache—Prednisone—atopic dermatitis	0.000145	0.000783	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—IL5—atopic dermatitis	0.000139	0.00133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL5—atopic dermatitis	0.000138	0.00132	CbGpPWpGaD
Tolvaptan—Nausea—Prednisone—atopic dermatitis	0.000138	0.000742	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	0.000137	0.00131	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	0.000131	0.00126	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—atopic dermatitis	0.000131	0.00125	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000129	0.00124	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL10—atopic dermatitis	0.000118	0.00114	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL10—atopic dermatitis	0.000117	0.00113	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000103	0.000992	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000103	0.000985	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL5—atopic dermatitis	0.000102	0.000977	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL5—atopic dermatitis	0.000101	0.00097	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—atopic dermatitis	9.89e-05	0.000948	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—atopic dermatitis	9.81e-05	0.000941	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—atopic dermatitis	9.52e-05	0.000913	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	9.46e-05	0.000908	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGF—atopic dermatitis	9.43e-05	0.000905	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—atopic dermatitis	9.39e-05	0.000901	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGF—atopic dermatitis	9.37e-05	0.000898	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—atopic dermatitis	9.33e-05	0.000894	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR5—atopic dermatitis	9.18e-05	0.00088	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR5—atopic dermatitis	9.11e-05	0.000874	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—atopic dermatitis	8.98e-05	0.000861	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—atopic dermatitis	8.91e-05	0.000855	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.77e-05	0.000841	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	8.54e-05	0.000819	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKBIA—atopic dermatitis	7.78e-05	0.000746	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKBIA—atopic dermatitis	7.73e-05	0.000741	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GLB1—atopic dermatitis	6.13e-05	0.000588	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.94e-05	0.000569	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADSL—atopic dermatitis	5.88e-05	0.000564	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—atopic dermatitis	5.55e-05	0.000532	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—atopic dermatitis	5.51e-05	0.000528	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—atopic dermatitis	5.3e-05	0.000509	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—atopic dermatitis	5.28e-05	0.000506	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—atopic dermatitis	5.26e-05	0.000505	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—atopic dermatitis	5.24e-05	0.000502	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—atopic dermatitis	4.88e-05	0.000468	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—atopic dermatitis	4.85e-05	0.000465	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.7e-05	0.000451	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.25e-05	0.000408	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.78e-05	0.000362	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.62e-05	0.000347	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—atopic dermatitis	3.12e-05	0.000299	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—atopic dermatitis	3.09e-05	0.000297	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARA—atopic dermatitis	1.99e-05	0.000191	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.23e-05	0.000118	CbGpPWpGaD
